Biogen (BIIB) Morgan Stanley raised the target to $373 from $361
Analyst Ratings Coverage Morgan Stanley & Co. (Rank#1) has recently issued a research report, maintaining its “Overweight” rating on Biogen’s stock, signaling…
Browse research
Analyst Ratings Coverage Morgan Stanley & Co. (Rank#1) has recently issued a research report, maintaining its “Overweight” rating on Biogen’s stock, signaling…
Canopy Growth’s Resilience Shows as Second-Quarter Core Loss Narrows Leading pot producer Canopy Growth has reported a smaller adjusted core loss for…
Q3 Earnings Beat Manulife Financial, Canada’s largest insurer, has demonstrated a robust financial performance in the third quarter, surpassing market expectations. The…
Suncor Energy Q3 Suncor Energy, one of Canada’s leading integrated energy companies, reported a third-quarter profit that exceeded market expectations. The impressive…
Rogers Q3 Revenue Surge Rogers Communications has announced a significant jump in its third-quarter revenue, meeting Wall Street estimates. The telecommunications giant…